These data are consistent with the observation that MDSCs producing high ARG1 exist in patients with renal cell carcinoma and express lower levels of T-cell receptor (TCR) and CD3-associated ζ chain [103], indicating that ARG1 plays a critical role in immunosuppression of MDSCs both in mice and in patients. This evidence concerns the gene ARG1 and renal cell carcinoma.